Ozempic for Seniors: Evidence, Eligibility, Coverage
Ozempic has no separate rule for adults 65 and older. It is approved for type 2 diabetes, heart risk and kidney disease in type 2 diabetes. In SELECT: heart attack, stroke, or death from heart disease: 6.5%, vs 8% on placebo.
- Active ingredient
- semaglutide
- How it is taken
- weekly injection
- Approved for
- Type 2 diabetes, heart risk and kidney disease in type 2 diabetes
- Best result (SELECT)
- heart attack, stroke, or death from heart disease: 6.5%
Ozempic overview
Its half-life is about 1 week: after 7 d, half is gone, and after five half-lives (35 d), about 3% remains.
In SUSTAIN 1 over 30 weeks, the type 2 diabetes group lost 4.7 kg, compared with 1.2 kg on placebo
In US dollars, the monthly figures include list prices and self-pay offers. Each figure comes from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.
Who qualifies?
| Source | Who qualifies |
|---|---|
| FDA label | Used with diet and exercise, it lowers blood sugar in adults who have type 2 diabetes. |
| FDA label | For adults with type 2 diabetes and heart disease, it lowers the chance of heart-related death, a heart attack, or a stroke |
| FDA label | In adults with type 2 diabetes and chronic kidney disease, it lowers the chance of kidney failure, of heart-related death, or of worsening kidney disease |
Label information: FDA label at DailyMed.
Trial results in seniors
This group includes trials of other brands that use the same ingredient, but no trial of Ozempic itself.
| Trial | Medicine | Who took part | Length | People | Main result | Comparison |
|---|---|---|---|---|---|---|
| SELECT |  Wegovy | Adults aged 45 and older with heart disease who were overweight or had obesity, and who did not have diabetes | 39.8 months (follow-up) | 17,604 | heart attack, stroke, or death from heart disease: 6.5% | 8% on placebo |
| SOUL |  Rybelsus | Type 2 diabetes plus either heart or kidney disease in adults aged 50 and older | 47.5 months (follow-up) | 9,650 | heart attack, stroke or heart disease death: 12% | 13.8% on placebo |
See SELECT (PubMed), SOUL (PubMed).
What is different for seniors?
| What changes | What the label says |
|---|---|
| Low Blood Sugar When Combined With Insulin Secretagogues or Insulin | Combining it with insulin or a sulfonylurea raises the chance of low blood sugar, and those doses may need to be lowered. |
| Acute Kidney Injury Due to Volume Depletion | Fluid loss from vomiting or diarrhea can lead to kidney injury. Drink fluids and report heavy fluid loss. |
| Taken with insulin or sulfonylureas | Insulin or sulfonylureas such as glipizide or glimepiride, taken with it, can increase your chance of low blood sugar. Your doctor may reduce the doses of either. |
As stated in the FDA labels: FDA label on DailyMed.
According to the label warnings: FDA label (DailyMed).
Coverage for seniors
For diabetes or cardiovascular disease, Medicare Part D may cover these medicines when they are prescribed
Part D plans may cover a GLP-1 for type 2 diabetes, fatty liver disease, or moderate to severe sleep apnea
When a GLP-1 is prescribed only for weight loss, no payment comes from Medicare Part D
When Medicaid covers weight-loss GLP-1s, prior authorization is the standard.
Sources: humana.com, medicare.gov, KFF.
- Ozempic Coupon
- Ozempic Cost
- Ozempic Cost Without Insurance
- Ozempic Cost With Insurance
- Is Ozempic Covered by Insurance? Criteria, Copay, Appeal
- Does Medicare Cover Ozempic? Part D Rules and the GLP-1 Bridge
- Ozempic Patient Assistance
- Cheapest Way to Get Ozempic
- Does Medicaid Cover Ozempic? Criteria, Copay, How to Appeal
Alternatives for seniors
| Medicine | For older adults | How it is taken | Trial result |
|---|---|---|---|
| Ozempic | Approved uses apply | weekly injection | Not listed |
| Wegovy | Approved uses apply | weekly injection or daily tablet | heart attack, stroke, or death from heart disease: 6.5% |
| Rybelsus | Approved uses apply | daily tablet | heart attack, stroke or heart disease death: 12% |
 Mounjaro | Approved uses apply | weekly injection | Not listed |
 Zepbound | Approved uses apply | weekly injection | Not listed |
 Foundayo | Approved uses apply | daily tablet | Not listed |
 Trulicity | Approved uses apply | weekly injection | heart attack, stroke or heart disease death: 12% |
 Saxenda | Approved uses apply | daily injection | Not listed |
 Victoza | Approved uses apply | daily injection | Not listed |
| Byetta | Approved uses apply | twice-daily injection | Not listed |
Sources: FDA label on DailyMed, PubMed.
Questions to ask your prescriber
- Does Medicare Part D coverage apply to me, or does the GLP-1 Bridge?
- How can we keep muscle while I lose weight?
- Of the medicines I take now, which could interact?
See the full Ozempic prescribing information on DailyMed.